Madrid, Spain

Manuel Guzman Pastor

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manuel Guzman Pastor: Innovator in Cannabinoid Research

Introduction

Manuel Guzman Pastor is a prominent inventor based in Madrid, Spain. He is known for his groundbreaking work in the field of cannabinoid research, particularly in relation to cancer treatment. His innovative approach has led to significant advancements in the medical application of cannabinoids.

Latest Patents

Manuel Guzman Pastor holds a patent for the "Anti-tumoural effects of cannabinoid combinations." This invention pertains to the use of a combination of cannabinoids, specifically tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for cancer treatment. The focus of this patent is on treating brain tumors, particularly gliomas, with an emphasis on glioblastoma multiforme (GBM). This patent highlights the potential of cannabinoids in addressing serious health challenges.

Career Highlights

Throughout his career, Guzman has made significant contributions to cannabinoid research. He has worked with notable companies such as GW Pharmaceuticals and Otsuka Pharmaceutical Company, Limited. His work has been instrumental in advancing the understanding of cannabinoids and their therapeutic applications.

Collaborations

Manuel Guzman Pastor has collaborated with esteemed colleagues in his field, including Guillermo Velasco Diez and Mar Lorente. These collaborations have further enriched his research and contributed to the development of innovative treatments.

Conclusion

Manuel Guzman Pastor is a key figure in cannabinoid research, with a focus on developing effective treatments for cancer. His patent on cannabinoid combinations showcases his commitment to advancing medical science. His contributions continue to inspire further research and innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…